Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition
Join Professor Luke O’Neill (Trinity College Dublin) and Dr Elise Malavasi ( Associate Director of Neurosciences Concept Life Sciences) for this webinar that explores recent advances in inflammasome science, and highlights how selecting appropriate in vitro models and meaningful readouts is essential for accurately assessing therapeutic potential.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Join LifeNet Health LifeSciences for our first Assay Services webinar, focusing on Dermal Absorption. This session explores in vitro permeation testing, a crucial method for assessing a compound’s potential to penetrate the skin and reach systemic circulation.
Using In Vitro Assays to Model Complex Biology with PhenoVista’s Assay Services
Learn about PhenoVista’s unique service offerings and how expertise in developing complex, in vitro studies to provide actionable and relevant data can help drive drug discovery forward.
Getting to the Heart of Cardiovascular Research: From Yesterday to Today and Looking Towards Tomorrow
Dr. Melanie White presents the various methods for assessing cardiac function in the context of pathology, spanning from in vitro to in vivo techniques, and how she integrates these with cutting-edge mass spectrometry in her research on cardiovascular disease pathogenesis.
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Translation
In this webinar, Dr. Louis Scott discusses the morph_ONE™ assay, a novel tool for in vitro safety assessment in drug development.
Industry Insights with Crown Bioscience: Targeting T Cells Within the Cancer-Immunity Cycle
In this episode of Industry Insights, Saskia De Man, PhD, Marrit Putker, PhD, and Pirouz Daftarian, PhD, from Crown Bioscience discuss assays and methods for evaluating T cell therapeutics, including organoids, co-cultures, and high content imaging.
Industry Insights with Crown Bioscience: In Vitro Technologies for Studying the Cancer-Immunity Cycle
In this episode of Industry Insights, Rajendra Kumari, PhD, and Gera Goverse, PhD, from Crown Bioscience answer questions about in vivo, in vitro, and ex vivo technologies and methods that can be used for immuno-oncology research along each step of the cancer-immunity cycle.
Organize and Streamline Data Collection with DMC LabBook
Matt Borkowski of Aurora Scientific discusses the latest software update for their Dynamic Muscle Control and Analysis Software, DMC LabBook
What is hyperoxia, normoxia and hypoxia to cells: Why researchers should care about environmental oxygen and how it influences results
An educational webinar providing an overview of the effects of oxygen concentration during in vitro cell culturing and how to accurately determine and regulate O2 levels during experiments.
#ExpertAnswers: Keshari Thakali and Aaron Stupica on Maternal Obesity Effects on Offspring
Dr. Keshari Thakali from the University of Arkansas for Medical Sciences and Aaron Stupica from DMT answer questions from a [...]
Studying Smooth and Striated Muscle Function Using Advanced Tissue Bath Systems
Aaron Stupica and Keshari Thakali discuss techniques tissue bath myography and present a unique case study looking at the effect of maternal obesity on offspring perivascular adipose tissue and vascular function.
